Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.13M 1.97M 1.82M 3.42M 234M 3.49M 23.47M 9.21M 115M 9.15M 8.95M 394M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.89M 10.06M 9.3M 17.51M 1.2B 17.83M 120M 47.09M 586M 46.79M 45.76M 2.02B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+2.27%-11.88% - - 20.64B
+3.43%+2.26%-32.34%+17.53% 16.32B
-5.65%-7.63%+6.00%+63.24% 7.51B
+0.43%+0.65%-50.94%-64.41% 7.76B
-0.43%-4.57%-28.33%+220.43% 4.31B
-1.74%+0.77%-36.39%-31.84% 2.29B
+0.90%-0.88%-37.82%-45.99% 1.75B
-1.07%-1.38%+3.57%+80.58% 1.51B
-1.37%-4.26%+3.94%+38.26% 1.44B
Average -0.28%-3.12%-21.54%+34.73% 6.35B
Weighted average by Cap. +0.88%-4.58%-26.55%+28.79%

Financials

2018 2019 *
Net sales 3.32M 2.9M 2.68M 2.48M 4.67M 319M 4.75M 32M 12.56M 156M 12.48M 12.2M 538M -
Net income -15.94M -13.93M -12.88M -11.9M -22.4M -1.53B -22.81M -154M -60.25M -750M -59.87M -58.55M -2.58B -
Net Debt 10.02M 8.76M 8.1M 7.48M 14.09M 963M 14.34M 96.55M 37.88M 471M 37.65M 36.81M 1.62B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock